Trusted Resources: News & Events
Latest announcements and gatherings
American Society of Gene & Cell Therapy (ASGCT) Policy Summit
This year’s Policy Summit will offer a variety of stakeholder perspectives on hot topics in the gene therapy field and how they inform regulatory, legislative, and payment policies for diagnosis and treatment.
Date:
September 22-24, 2021
+myBinderRelated Content
-
Cheedy Jaja, PhDDr. Cheedy Jaja is an associate professo...
-
Sickle cell disease, sickle trait and the risk for venous thromboembolism: A systematic review and meta-analysisBackground: Globally, sickle cell disea...
-
The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitati...Overt ischaemic stroke is one of the mos...
-
Today’s Faces of Sickle Cell Disease: Tesha SamuelsTesha Samuels was diagnosed with SCD at ...
-
A Teenager’s Breakthrough Gene Therapy for Sickle Cell DiseaseMeet Helen Obando, a shy 16-year-old who...
-
2017 LEADERSHIP SUMMIT & GENERAL ASSEMBLYThe Sickle Cell Community Consortium is ...
-
CTX001 Continues to Show Promise in Severe SCDA single dose of CTX001, an experimental...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.